IL15 and glioma: Furthermore, engineered oncolytic viruses like Ad5-Ki67/IL-15 demonstrate dual functionality: not only eliminating TA-MSCs but also reversing their immunosuppressive effects on glioma cells through PD-L1 downregulation and angiogenesis inhibition [37].